Amanote Research
Register
Sign In
58. Engineering a Novel Retroviral Envelope to Retarget Retroviral Vectors
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)35071-7
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2014
Authors
Unknown
Publisher
Elsevier BV
Related search
PostexitSurface Engineering of Retroviral/Lentiviral Vectors
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Q Vectors, Bicistronic Retroviral Vectors for Gene Transfer
BioTechniques
Biochemistry
Biotechnology
Genetics
Molecular Biology
A New Generation of pPRIG-based Retroviral Vectors
BMC Biotechnology
Biotechnology
Self-Inactivating Retroviral Vectors With Improved RNA Processing
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
E- Vectors: Development of Novel Self-Inactivating and Self-Activating Retroviral Vectors for Safer Gene Therapy.
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Introduction for “Safety Considerations for Retroviral Vectors: A Short Review”
Applied Biosafety
Management
Monitoring
Mutagenesis
Public Health
Environmental
Health
Toxicology
Policy
Biotechnology
Law
Occupational Health
Regulation of Mammary Hormone Receptor Metabolism by a Retroviral Envelope Protein
Journal of Molecular Endocrinology
Endocrinology
Molecular Biology
Kinetic Analyses of Stability of Simple and Complex Retroviral Vectors
Virology
Virology
278. Challenges in the Manufacturing of Retroviral Gene Therapy Vectors
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery